Patents by Inventor Kazuki SHIMANE

Kazuki SHIMANE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION THAT INHIBITS PRODUCTION OF HEPATITIS B VIRUS PROTEIN AND SCREENING METHOD
    Publication number: 20220042020
    Abstract: An object of the present invention is to provide a pharmaceutical composition useful as a novel anti-hepatitis B virus agent and a screening method. According to the present invention, there is provided a pharmaceutical composition that inhibits a production of a hepatitis B virus protein, in which the pharmaceutical composition inhibits an expression or a function of an RNA-binding protein that binds to at least one sequence selected from a hepatitis B virus RNA sequence corresponding to an enhancer I region sequence on a hepatitis B virus genome DNA or a hepatitis B virus RNA sequence corresponding to an enhancer II region sequence on the hepatitis B virus genome DNA.
    Type: Application
    Filed: September 23, 2021
    Publication date: February 10, 2022
    Applicants: FUJIFILM Corporation, PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY
    Inventors: Yasuhito TANAKA, Ryota HABA, Kazuki SHIMANE, Takaki KAWANO
  • PHARMACEUTICAL COMPOSITION THAT INHIBITS PRODUCTION OF HEPATITIS B VIRUS PROTEIN, PHARMACEUTICAL COMPOSITION FOR TREATING HEPATITIS B, AND SCREENING METHOD
    Publication number: 20220000903
    Abstract: An object of the present invention is to provide a pharmaceutical composition useful as a novel anti-hepatitis B virus agent and a screening method. According to the present invention, there is provided a pharmaceutical composition that inhibits the production of a hepatitis B virus protein, in which the pharmaceutical composition inhibits the expression or the function of a protein belonging to the YTHDC family.
    Type: Application
    Filed: September 23, 2021
    Publication date: January 6, 2022
    Applicant: FUJIFILM Corporation
    Inventors: Ryota HABA, Kazuki SHIMANE, Nozomi YAMASHITA
  • Anti-hepatitis B virus agent
    Patent number: 10308642
    Abstract: An anti-hepatitis B virus agent comprising a compound represented by general formula [1], wherein R1 represents an aryl group, which may be substituted, or the like; R2 represents an aryl group, which may be substituted, or the like; and R3 represents a hydrogen atom or the like; or a salt thereof.
    Type: Grant
    Filed: October 5, 2016
    Date of Patent: June 4, 2019
    Assignees: FUJIFILM Toyama Chemical Co., Ltd., PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY
    Inventors: Kazuki Shimane, Yasuhito Tanaka
  • ANTI-HEPATITIS B VIRUS AGENT
    Publication number: 20180291011
    Abstract: An anti-hepatitis B virus agent comprising a compound represented by general formula [1], wherein R1 represents an aryl group, which may be substituted, or the like; R2 represents an aryl group, which may be substituted, or the like; and R3 represents a hydrogen atom or the like; or a salt thereof.
    Type: Application
    Filed: October 5, 2016
    Publication date: October 11, 2018
    Applicants: TOYAMA CHEMICAL CO., LTD., PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY
    Inventors: Kazuki SHIMANE, Yasuhito TANAKA